Transgender Top Surgery in 2026: What the New Federal Order and ASPS Guidelines Mean for Patients and Families
- Feb 28
- 3 min read
Evidence-based, patient-centered guidance and future surgical planning.
Transgender top surgery is a deeply personal and often life-changing step for many individuals experiencing gender dysphoria. In 2026, two major developments reshaped the landscape of care for adolescents:
A federal executive order prohibiting gender-related surgical procedures for patients under age 19
A February 3, 2026 position statement from the American Society of Plastic Surgeons (ASPS) recommending that surgeons delay gender-related breast/chest, genital, and facial surgery until at least age 19 (The full publication is available at the bottom of this blog post.)
This article explains what that means — medically, ethically, and practically — while reaffirming our commitment to compassionate, patient-centered care.
What Is Transgender Top Surgery?
Transgender top surgery refers to surgical procedures that align a person’s chest with their gender identity.
For transgender men and transmasculine patients, this typically includes:
Bilateral mastectomy
Chest contouring
Nipple-areolar repositioning or grafting
For transgender women and transfeminine patients, this may include breast augmentation.
For many adults, these procedures are associated with improved body congruence and relief of gender dysphoria. However, the discussion surrounding surgery in adolescents has evolved significantly.
What the 2026 ASPS Position Statement Says
In February 2026, ASPS issued a formal position statement addressing gender surgery in children and adolescents.
Key Conclusions from ASPS:
The current evidence base is low or very low certainty regarding long-term mental health and psychosocial outcomes in minors.
The natural course of pediatric gender dysphoria is not fully understood.
There are no reliable tools to predict which adolescents will experience persistent gender dysphoria into adulthood.
Irreversible surgical procedures require a clear favorable risk–benefit profile — which ASPS states has not yet been demonstrated for minors.
ASPS therefore recommends:
Surgeons delay gender-related breast/chest, genital, and facial surgery until a patient is at least 19 years old.
Importantly, ASPS also affirms:
Respect for patient dignity
Compassionate care for transgender individuals
Opposition to criminalization of medical care
Ongoing review as higher-quality evidence emerges
This is not a denial of patient experience. It is a precautionary stance based on current evidence standards and ethical considerations in pediatric medicine.
The Federal Executive Order: Why Hospitals Are Changing Policy
In addition to the ASPS recommendation, a federal executive order now prohibits gender-related surgical procedures for patients under 19.
Hospitals that do not comply risk:
Loss of federal funding
Loss of Medicare participation
Loss of Medicaid participation
Because Medicare and Medicaid access are foundational to hospital operations, nearly all hospital systems are choosing compliance.
As a result:
Hospitals are no longer permitting gender-related surgery for patients under 19, regardless of prior state-level policies.
This shift is driven by federal funding risk — not by a change in compassion for patients.
Our Commitment to Patients Under 19
While surgical intervention must now be delayed until at least age 19, our commitment to patients does not end there.
We will continue to see patients under 19 in a supportive and planning-focused role, including:
Education about surgical options
Discussion of timing and candidacy
Long-term planning for surgical intervention after age 19
Collaboration with mental health providers
Preparing patients emotionally and medically for future procedures
Early consultation does not mean early surgery. It means thoughtful preparation.
Our goal is to ensure that when a patient reaches age 19, they are:
Fully informed
Developmentally ready
Medically optimized
Emotionally supported
We believe supportive care today strengthens outcomes tomorrow.
A Patient-Centered Perspective
We understand that for many patients and families, this change may feel disappointing or distressing.
It is important to say clearly:
Your experience is real.
Your distress is real.
Your identity is respected.
Delaying surgery does not invalidate your journey.
The ASPS statement emphasizes that ethical pediatric care requires balancing compassion with scientific rigor, especially when procedures are irreversible and long-term outcomes remain uncertain.
Our role is to:
Provide accurate, evidence-based information
Avoid unnecessary harm
Support long-term wellbeing
Maintain dignity and respect at every stage
Frequently Asked Questions
Can my teen still have a consultation?
Yes. We will continue to offer consultations focused on education and long-term planning.
Does this mean surgery is no longer available at all?
Surgery remains available for patients age 19 and older.
Could this change again?
Possibly. ASPS has committed to ongoing review of emerging evidence and may revisit recommendations if higher-quality data demonstrate clear benefit with acceptable risk.
The Evolving Standard of Care
The 2026 ASPS position statement and federal executive order represent a major shift in the treatment landscape for transgender adolescents.
Current guidance reflects:
Low-certainty evidence in minors
Ethical concerns about irreversible interventions
Institutional realities tied to federal funding
What has not changed is the commitment to compassionate, respectful care.
Comments